跳至主要内容
临床试验/NCT04768595
NCT04768595Unknown不适用

A Nutritional, Placebo Controlled, Randomised, Blinded Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex)

Epax Norway AS2 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2021年3月3日最近更新:
适应症

试验速览

阶段
不适用
入组人数
56
试验地点
2
主要终点
Change in Omega-3 index

研究概览

简要总结

The study determines the EPA DHA uptake from different omega-3 supplements against a control.

详细描述

The chronic uptake of omega-3 fatty acids EPA and DHA are commonly determined by measurement of EPA and DHA in red bloods cells and presented as a % of total fatty acids, the so-called Omega-3 Index. The index is a validated risk assessment for cardiovascular disease. Different fish oils may influence the Omega-3 Index differently depending on their composition. This study assesses omega-3 commonly found as a supplement vs a fish oil based on north atlantic fish species.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

盲法说明

Fish oil or placebo are given as gelatin capsules packaged in identical white bottles.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women, ≥18 -65 years of age.
  • Willing to refrain from taking omega-3 supplements for 1 month prior to study start
  • Willing to take study supplement for 2 months

排除标准

  • Subjects with known allergy to fish products
  • Subjects known to be pregnant or breast feeding

结局指标

主要结局

Change in Omega-3 index

时间窗: Baseline (supplementation start: time point 0) to 2 months of supplementation

Change in the omega-3 index (EPA and DHA content as a % of total fatty acids in red blood cells) from baseline to end of supplementation

次要结局

  • Change in fatty acid profile from baseline to end of supplementation between study arms.(Baseline to 2 months of supplementation.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验